SUBSCRIBE
SUBSCRIBE

Washington State

3D illustration of neurons
Alzheimer’s disease
Athira’s Small Molecule Injection for Alzheimer’s Flops in Phase II/III Study
The investigational injection fosgonimeton appeared to have better efficacy in patients with more severe disease, according to post-hoc subgroup analyses, though none resulted in statistically significant effects.
September 4, 2024
 · 
2 min read
 · 
Tristan Manalac
Load More
PRESS RELEASES
Press Releases
Omeros Announces Successful Primate Study in OncotoX-AML™ Drug Program
February 17, 2026
 · 
5 min read
Press Releases
Danaher To Acquire Masimo Corporation
February 17, 2026
 · 
15 min read
Press Releases
Vivos Inc. Diversifies Manufacturing Base with Planned U.S. and International Production Sites
February 17, 2026
 · 
2 min read
Press Releases
Magnolia Medical Welcomes Sarah Huber as Senior Vice President, Sales
February 12, 2026
 · 
3 min read
Press Releases
Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
February 12, 2026
 · 
18 min read
Press Releases
Atossa Therapeutics Issues Letter to Shareholders Highlighting 2025 Accomplishments and 2026 Outlook
February 11, 2026
 · 
14 min read
Press Releases
Vivos Inc. Announces Significant Progress Toward FDA Investigational Device Exemption (IDE) Submission for RadioGel® Precision Radionuclide Therapy™
February 10, 2026
 · 
4 min read
Press Releases
National Organization for Rare Disorders Ranks All 50 States on Rare Disease Policies
February 10, 2026
 · 
4 min read
Press Releases
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 5, 2026
February 6, 2026
 · 
1 min read
Press Releases
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2025 Financial Results
February 6, 2026
 · 
15 min read
Press Releases
Atossa Therapeutics Maintains Strong Market Position for (Z)-Endoxifen for Duchenne Muscular Dystrophy as Congress Reauthorizes Priority Review Voucher Program
February 5, 2026
 · 
6 min read
Press Releases
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
February 5, 2026
 · 
1 min read
Press Releases
Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026
February 5, 2026
 · 
1 min read
Press Releases
/C O R R E C T I O N -- Chamber Cardio/
February 5, 2026
 · 
3 min read
Press Releases
Immunome to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026
February 5, 2026
 · 
1 min read
Press Releases
Chamber Raises $60 Million in Series A Funding to Drive the Future of Cardiology Value-Based Care
February 5, 2026
 · 
3 min read
Press Releases
AGC Biologics Seattle Site Now Certified to Manufacture Biologics for Largest Pharmaceutical Market in South America
February 4, 2026
 · 
4 min read
Press Releases
Aptevo Announces Executive Leadership Transitions to Support Next Phase of Growth
February 3, 2026
 · 
11 min read
Press Releases
LeonaBio Appoints Industry Veteran Mark F. Kubik as Chief Business Officer
February 3, 2026
 · 
8 min read
Press Releases
AHF: Drain the Apexus Swamp
February 3, 2026
 · 
2 min read
Load More